Literature DB >> 35707157

Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID： 35707157      PMCID： PMC9190286          DOI： 10.1021/acsmedchemlett.2c00193

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedema.

Authors:  Bob Geng; Timothy J Craig
Journal:  Ann Allergy Asthma Immunol       Date:  2021-10-18       Impact factor: 6.347

Review 2.  It is time for a moonshot to find "Cures" for diabetic retinal disease.

Authors:  S Robert Levine; Przemyslaw Sapieha; Sanjoy Dutta; Jennifer K Sun; Thomas W Gardner
Journal:  Prog Retin Eye Res       Date:  2022-02-11       Impact factor: 19.704

Review 3.  Diabetic retinopathy, oxidative stress, and sirtuins: an in depth look in enzymatic patterns and new therapeutic horizons.

Authors:  Marcella Nebbioso; Alessandro Lambiase; Marta Armentano; Giosuè Tucciarone; Marta Sacchetti; Antonio Greco; Ludovico Alisi
Journal:  Surv Ophthalmol       Date:  2021-04-14       Impact factor: 6.048

Review 4.  An update on factor XII-driven vascular inflammation.

Authors:  Reiner K Mailer; Chandini Rangaswamy; Sandra Konrath; Jonas Emsley; Thomas Renné
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-10-24       Impact factor: 4.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.